Thus, the decreased plasma IL-17 and IL-23 level in survivors implicate a remarkable reduction of organ injury induced by ischemia, whereas the elevation of IL-17 in non-survivors suggests an aggravation of ischemic injury. The gene discussed is IL17A; the disease is ischemia.